Skip to main content
Log in
Sciensano
Support
Belgian Genetic Tests database
Toggle navigation
Main navigation
Home
Genetic tests
Analytes
Diseases
Labs
Guide
Contact
Genetic tests
20
50
100
Search
Reset
Full name
Analytes
Gene panels
Disease
Laboratory
41 pharmacogenes analysis
pharmacogenes analysis
Centre de Génétique Médicale UCL
5-fluorouracil (5-FU) toxicity - DPYD sequencing (all exons) - Pharmacogenetics
DPYD
5-fluorouracil toxicity
Centre de Génétique Médicale UCL
5-fluorouracil toxicity - DPYD genotyping (4 hot spot mutations - DPYD*2A, DPYD*13, D949V, HapB3) - Pharmacogenetics
DPYD
5-fluorouracil toxicity
Centre de Génétique Médicale UCL
Abacavir toxicity (HLA-B*57:01 genotyping) - Pharmacogenetics
HLA-B
Abacavir toxicity
Centrum Medische Genetica - UZ Brussel VUB
Abacavir toxicity (HLA-B*57:01 genotyping) - Pharmacogenetics
HLA-B
Abacavir toxicity
Centre de Génétique Humaine - CHU Sart-Tilman
Abacavir toxicity (HLA-B*57:01 genotyping) - Pharmacogenetics
HLA-B
Abacavir toxicity
Centrum Medische Genetica - UZ Gent
ABCB1 genotyping (c.3435C>T, c.1199G>A ) - Transport protein - Pharmacogenetics
ABCB1
Resistance to colchicine
Centre de Génétique Médicale UCL
Breast and Ovarian Cancer, HBOC, Familial (17 genes)
BRCA1
,
BRCA2
,
TP53
,
PALB2
,
CHEK2
,
ATM
,
BRIP1
,
RAD51C
,
RAD51D
,
MLH1
,
MSH2
,
MSH6
,
BARD1
,
CDH1
,
EPCAM
,
PMS2
,
PTEN
Hereditary breast and/or ovarian cancer syndrome
Centre de Génétique Médicale UCL
Breast and Ovarian Cancer, HBOC, Hereditary
Breast and ovarian cancer - UGent
Hereditary breast cancer
,
Hereditary breast and/or ovarian cancer syndrome
Centrum Medische Genetica - UZ Gent
Breast cancer, hereditary (gene panel)
Extended Breast Cancer Panel (26 gene) - VUB
Centrum Medische Genetica - UZ Brussel VUB
Breast Cancer Trial
BRCA1
,
BRCA2
Centrum Menselijke Erfelijkheid - KUL
Colon carcinoma (hereditary/familial) (gene panel)
Colon carcinoma (hereditary/familial) (gene panel) (12 genes) - VUB
APC-related attenuated familial adenomatous polyposis
,
Familial adenomatous polyposis
,
Familial colorectal cancer Type X
,
Generalized juvenile polyposis/juvenile polyposis coli
,
Hereditary mixed polyposis syndrome
,
Hereditary nonpolyposis colorectal cancer
,
Lynch syndrome
,
MUTYH-related attenuated familial adenomatous polyposis
Centrum Medische Genetica - UZ Brussel VUB
CYP2B6*6,*11,*18 genotyping - drug metabolism - Pharmacogenetics
CYP2B6
Efavirenz toxicity
Centre de Génétique Médicale UCL
CYP2C19*2,*3,*17 genotyping - drug metabolism - Pharmacogenetics
CYP2C19
Antidepressant or antipsychotic toxicity or dose selection
,
Resistance to clopidogrel
,
Voriconazole toxicity
Centre de Génétique Médicale UCL
CYP2C9*2,*3 genotyping - drug metabolism - Pharmacogenetics
CYP2C9
Vitamin K antagonists toxicity or dose selection
,
Oral antidiabetic drugs toxicity or dose selection
Centre de Génétique Médicale UCL
CYP2D6 genotyping (full gene sequencing + pseudogene and CNV analysis)- drug metabolism - Pharmacogenetics
CYP2D6
Codeine toxicity
,
Resistance to tamoxifene
,
Antidepressant or antipsychotic toxicity or dose selection
Centre de Génétique Médicale UCL
CYP3A4*22 genotyping - drug metabolism - Pharmacogenetics
CYP3A4
Tacrolimus dose selection
Centre de Génétique Médicale UCL
CYP3A5*3 genotyping - drug metabolism - Pharmacogenetics
CYP3A5
Tacrolimus dose selection
Centre de Génétique Humaine - CHU Sart-Tilman
Pagination
Current page
1
Page
2
Page
3
Next page
Next ›
Last page
Last »
Download XLSX
Download PDF
Did not find what you were looking for? Contact us through the support center.
Read more